Placental stem cells: The promise of curing diseases before birth

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Regenerative medicine is a rapidly expanding and promising field for many diseases and injuries. Stem cells for regenerative therapies have originally been obtained from bone marrow, but are now readily extracted from a variety of adult tissues. Fetal tissue has recently garnered interest for its ease of differentiation into a variety of phenotypes and its relative abundance of pluripotent-linked transcription factors. However, much ethical concern surrounds the methods of obtaining fetal cells. The placenta has emerged as a potential source of fetal derived cells due to its favorable technical and ethical characteristics, as well as its promising therapeutic properties. This preview focuses on providing on overview on the derivation and characteristics of placental derived stem cells as well as delving into their various clinical applications and potential future directions.

Original languageEnglish (US)
JournalPlacenta
DOIs
StateAccepted/In press - Feb 15 2017

Fingerprint

Stem Cells
Parturition
Regenerative Medicine
Cell- and Tissue-Based Therapy
Placenta
Fetus
Transcription Factors
Bone Marrow
Phenotype
Wounds and Injuries
Therapeutics
Direction compound

Keywords

  • Birth defect
  • Congenital anomaly
  • Fetal surgery
  • In utero transplantation
  • Mesenchymal stromal cells
  • Placental stem cell

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology
  • Developmental Biology

Cite this

Placental stem cells : The promise of curing diseases before birth. / Farmer, Diana L.

In: Placenta, 15.02.2017.

Research output: Contribution to journalArticle

@article{bfd1316e4ad84cf59c8174b2182d0136,
title = "Placental stem cells: The promise of curing diseases before birth",
abstract = "Regenerative medicine is a rapidly expanding and promising field for many diseases and injuries. Stem cells for regenerative therapies have originally been obtained from bone marrow, but are now readily extracted from a variety of adult tissues. Fetal tissue has recently garnered interest for its ease of differentiation into a variety of phenotypes and its relative abundance of pluripotent-linked transcription factors. However, much ethical concern surrounds the methods of obtaining fetal cells. The placenta has emerged as a potential source of fetal derived cells due to its favorable technical and ethical characteristics, as well as its promising therapeutic properties. This preview focuses on providing on overview on the derivation and characteristics of placental derived stem cells as well as delving into their various clinical applications and potential future directions.",
keywords = "Birth defect, Congenital anomaly, Fetal surgery, In utero transplantation, Mesenchymal stromal cells, Placental stem cell",
author = "Farmer, {Diana L}",
year = "2017",
month = "2",
day = "15",
doi = "10.1016/j.placenta.2017.04.022",
language = "English (US)",
journal = "Placenta",
issn = "0143-4004",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Placental stem cells

T2 - The promise of curing diseases before birth

AU - Farmer, Diana L

PY - 2017/2/15

Y1 - 2017/2/15

N2 - Regenerative medicine is a rapidly expanding and promising field for many diseases and injuries. Stem cells for regenerative therapies have originally been obtained from bone marrow, but are now readily extracted from a variety of adult tissues. Fetal tissue has recently garnered interest for its ease of differentiation into a variety of phenotypes and its relative abundance of pluripotent-linked transcription factors. However, much ethical concern surrounds the methods of obtaining fetal cells. The placenta has emerged as a potential source of fetal derived cells due to its favorable technical and ethical characteristics, as well as its promising therapeutic properties. This preview focuses on providing on overview on the derivation and characteristics of placental derived stem cells as well as delving into their various clinical applications and potential future directions.

AB - Regenerative medicine is a rapidly expanding and promising field for many diseases and injuries. Stem cells for regenerative therapies have originally been obtained from bone marrow, but are now readily extracted from a variety of adult tissues. Fetal tissue has recently garnered interest for its ease of differentiation into a variety of phenotypes and its relative abundance of pluripotent-linked transcription factors. However, much ethical concern surrounds the methods of obtaining fetal cells. The placenta has emerged as a potential source of fetal derived cells due to its favorable technical and ethical characteristics, as well as its promising therapeutic properties. This preview focuses on providing on overview on the derivation and characteristics of placental derived stem cells as well as delving into their various clinical applications and potential future directions.

KW - Birth defect

KW - Congenital anomaly

KW - Fetal surgery

KW - In utero transplantation

KW - Mesenchymal stromal cells

KW - Placental stem cell

UR - http://www.scopus.com/inward/record.url?scp=85018982700&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018982700&partnerID=8YFLogxK

U2 - 10.1016/j.placenta.2017.04.022

DO - 10.1016/j.placenta.2017.04.022

M3 - Article

C2 - 28477969

AN - SCOPUS:85018982700

JO - Placenta

JF - Placenta

SN - 0143-4004

ER -